Clinical observation on hyperbaric oxygenation combined with 0.025%ipratropium bromide inhalation in treatment of patients with stable chronic obstructive pulmonary disease
10.3969/j.issn.1005-1678.2016.04.51
- VernacularTitle:高压氧联合0．025％异丙托溴铵雾化吸入对稳定期慢性阻塞性肺疾病患者的疗效观察
- Author:
Wenjing LIANG
;
Manxing HUANG
;
Yanfeng LI
;
Haiming ZHONG
- Publication Type:Journal Article
- Keywords:
stable chronic obstructive pulmonary disease;
hyperbaric oxygenation;
ipratropium bromide;
aerosol inhalation;
pulmonary function
- From:
Chinese Journal of Biochemical Pharmaceutics
2016;36(4):161-163,166
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical efficacy on hyperbaric oxygenation combined with 0.025% ipratropium bromide inhalation in treatment of patients with stable chronic obstructive pulmonary disease( COPD) .Methods 86 elderly patients with stable COPD were divided into control group (n=42)and observation group(n=44)according to therapeutic methods.The patients in both groups were firstly given the conventional treatment such as oxygen inhalation, anti-infection, eliminating phlegm and reliving asthma, nutritional support, spasmolysis as well as a balance of water, electrolyte and PH.And the patients of the observation group were given hyperbaric oxygenation combined with 0.025% ipratropium bromide inhalation on basis of the conventional treatment.The clinical effects of the two groups were compared.Results In the control group, there were no statistical differences in parameters of pulmonary function before and after the treatment.However, after treatment, the relative index level of pulmonary function in the observation group was significantly higher than that of pre-treatment and that of the control group after treatment(P<0.05).After treatment, PaO2, SaO2 and pH of the two groups were significantly higher than those of pre-treatment(P<0.05).The level of PaCO2 in the two groups was significantly lower than that of pre-treatment(P<0.05).Also, the difference in PaO2, PaCO2 and SaO2 level was statistically significant before and after treatment between thw two groups(P<0.05).The scores of each dimension in PSQI scale of both groups were significantly lower than those of pre-treatment(P<0.05).And the scores of each dimension in PSQI scale of observation group was significantly lower than those of the control group after treatment(P<0.05).Whole blood cholinesterase activity of both groups was obviously greater than before treatment between theo two groups(P<0.05).Serum creatinine level of both groups were obviously lower than those of pre-treatment(P<0.05),and the differences in two groups in both blood cholinesterase activity and serum creatinine level were statistically significant ( P<0.05 ) .Conclusion The combination of high pressure oxygen and 0.025%ipratropium bromide for patients with stable COPD has a very significant clinical efficacy.It can effectively improve cholinesterase activity and lower serum creatinine level.
